Alumbre, Mary Crissanine .
HRN: 22-66-53 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2023
CEFUROXIME 1.5GM (VIAL)
06/19/2023
06/19/2023
IV
1.5gm
LD
Primary CS
Waiting Final Action
06/19/2023
CEFUROXIME 1.5GM (VIAL)
06/19/2023
06/26/2023
IV
1.5 Grams
Q8
SP 1LTCS
Waiting Final Action